PatriciaYvonneFechnerMD
Pediatric Endocrinology • Seattle, WAMedical Director, Differences in Sex Development Program at Seattle Children's, Medical Director, Center of Excellence for CAH at Seattle Children’s, Co-Director, Turner Syndrome Clinic at Seattle Children’s
Dr. Fechner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4800 Sand Poin Way Ne
M/S OC.7.820
Seattle, WA 98105Phone+1 206-987-5037Fax+1 206-985-3373- Is this information wrong?
Summary
- Patricia Fechner, MD, is attending physician at Seattle Childrens Hospital and professor of pediatrics at the University of Washington School of Medicine. Her clinical and research interests include Turner syndrome, androgen insensitivity syndrome and other disorders of sex determination as well as growth hormone and IGF-1 deficiency. She is the medical director of the DSD program and co-director of the Turner syndrome clinic. She serves as the contributing editor for the section of endocrinology AAP Grand Rounds and as consulting editor for GeneReviews.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1989 - 1993
University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1986 - 1989
Northwestern University The Feinberg School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - 2026
WA State Medical License 2006 - 2025
MD State Medical License 1993 - 2000- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- Decision Support for Parents Receiving Information About Child's Rare Disease Start of enrollment: 2013 Jun 01
- Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) Start of enrollment: 2020 Dec 31
- Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study) Start of enrollment: 2021 Jun 24
Publications & Presentations
PubMed
- 1 citationsDevelopment and validation of a computable phenotype for Turner syndrome utilizing electronic health records from a national pediatric network.Huang, S., Bothwell, S., Furniss, A., Pyle, L., Seyoum, H., Davis, S., Bamba, V., Fechner, P., Ikomi, C., Nahata, L., Nokoff, N.> ;American Journal of Medical Genetics. Part A. 2024 Apr 1
- Development and Validation of a Computable Phenotype for Turner Syndrome Utilizing Electronic Health Records from a National Pediatric Network.Sarah D Huang, Vaneeta Bamba, Samantha Bothwell, Patricia Y Fechner, Anna Furniss, Chijioke Ikomi, Leena Nahata, Natalie J Nokoff, Laura Pyle, Helina Seyoum, Shanlee M...> ;Medrxiv. 2023 Jul 23
- Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.Ron S Newfield, Kyriakie Sarafoglou, Patricia Y Fechner, Natalie J Nokoff, Richard J Auchus, Maria G Vogiatzi, George S Jeha, Nagdeep Giri, Eiry Roberts, Julia Sturgeo...> ;The Journal of Clinical Endocrinology and Metabolism. 2023 Oct 18
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Seattle Children's HospitalSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
